Similar to our data, Jin et al. reported that METTL3-induced m6A methylation and stabilization of MALAT1 contributed to drug resistance and metastasis of non-small-cell lung cancer [10]. This evidence concerns the gene METTL3 and non-small cell lung carcinoma.